methoxyhydroxyphenylglycol has been researched along with Schizophrenia in 186 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 104 (55.91) | 18.7374 |
1990's | 55 (29.57) | 18.2507 |
2000's | 10 (5.38) | 29.6817 |
2010's | 15 (8.06) | 24.3611 |
2020's | 2 (1.08) | 2.80 |
Authors | Studies |
---|---|
Atake, K; Hori, H; Katsuki, A; Yoshimura, R | 1 |
Iyo, M; Kanahara, N; Kimura, H; Nakata, Y; Takase, M | 1 |
Agartz, I; Andreou, D; Hjärpe, J; Jönsson, EG; Sedvall, GC; Söderman, E | 1 |
Kanno-Nozaki, K; Katsumi, A; Mashiko, H; Miura, I; Niwa, S; Shiga, T; Yabe, H | 1 |
Hino, M; Horikoshi, S; Kanno-Nozaki, K; Mashiko, H; Miura, I; Niwa, S; Ota, T; Yabe, H | 1 |
Horikoshi, S; Kanno-Nozaki, K; Mashiko, H; Miura, I; Niwa, S; Watanabe, K; Yabe, H | 1 |
Atake, K; Hori, H; Igata, R; Katsuki, A; Konishi, Y; Nakamura, J; Yoshimura, R | 1 |
Agartz, I; Andreou, D; Bjerkenstedt, L; Comasco, E; Flyckt, L; Johansson, J; Jönsson, EG; Lewander, T; Oreland, L; Söderman, E; Terenius, L; Toffoletto, S; Venizelos, N; Vumma, R | 1 |
Atake, K; Beppu, H; Hori, H; Igata, R; Katsuki, A; Konishi, Y; Tominaga, H; Yoshimura, R | 1 |
Goto, N; Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Kakeda, S; Korogi, Y; Moriya, J; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R | 2 |
Baumann, P; Hertel, A; Kehr, J; Kiessling, B; Mathé, AA; Nikisch, G; Piel, M; Reinert, M; Roesch, F; Schneider, P; Weisser, H; Wiedemann, G | 1 |
Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
Baumann, P; Hertel, A; Kehr, J; Kiessling, B; Mathé, AA; Nikisch, G; Weisser, H; Wiedemann, G; Yoshitake, T | 1 |
Sanada, H; Yoneda, M | 2 |
Kanno, K; Katsumi, A; Mashiko, H; Miura, I; Mori, A; Niwa, S; Numata, Y; Takeuchi, S; Yang, Q | 1 |
Atake, K; Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Tomita, M; Umene-Nakano, W; Yoshimura, R | 1 |
Kanno, K; Katsumi, A; Mashiko, H; Miura, I; Niwa, S; Takeuchi, S; Watanabe, K | 1 |
Aymard, N; Caroli, F; Clement, MN; Gauillard, J; Jacquot, M; Vacheron, MN; Viala, A | 1 |
Henning, U; Klimke, A; Oades, RD; Rao, ML | 1 |
Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R | 2 |
Goto, M; Kaji, K; Kakihara, S; Matsumoto, C; Nakamura, J; Ohmori, O; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R | 1 |
Hori, H; Ida, Y; Ikenouchi, A; Mitoma, M; Nakamura, J; Yamada, Y; Yoshimura, R | 1 |
Hori, H; Kakihara, S; Mitoma, M; Nakamura, J; Nakano, Y; Ohta, M; Shinkai, K; Shinkai, T; Sugita, A; Ueda, N; Umene, W; Yoshimura, R | 1 |
Chen, YF | 2 |
Berman, KF; Buchsbaum, MS; Caton, C; DeLisi, LE; Kafka, MS; Karoum, F; Mirsky, AF; Ninan, PT; Phelps, BH; van Kammen, DP | 1 |
Garelis, E; Markianos, M; Tripodianakis, J | 1 |
Macfie, C | 1 |
Sedvall, GC; Wode-Helgodt, B | 1 |
Sedvall, G | 1 |
Linkowski, P; Mendlewicz, J; Uytdenhoef, P | 1 |
Cajal, S; Etienne, P; Gauthier, S; Lal, S; Nair, NP; Wood, PL | 1 |
Buchsbaum, MS; Haier, RJ | 1 |
Cooper, SJ; King, DJ; Liddle, J | 1 |
Davis, BM; Davis, KL; Levy, MI; Mathé, AA; Mohs, RC; Trigos, GC | 1 |
Bartfai, A; Levander, SE; Sedvall, G | 1 |
Berggren, BM; Hindmarsh, T; Nybäck, H; Sedvall, G; Wiesel, FA | 1 |
Bartko, J; Chang, WH; Linnoila, M; Ninan, PT; Scheinin, M; van Kammen, DP; Waters, RN | 1 |
Alfredsson, G; Bjerkenstedt, L; Edman, G; Härnryd, C; Oxenstierna, G; Sedvall, G; Wiesel, FA | 1 |
Bjerkenstedt, L; Gullberg, B; Härnryd, C; Oxenstierna, G; Sedvall, G; Wiesel, FA | 1 |
Doongaji, DR; Jeste, DV; Linnoila, M | 1 |
Linnoila, M; Ninan, PT; Scheinin, M; van Kammen, DP | 1 |
Brouwer, GJ; Ceulemans, DL; de Wied, D; Kahn, RS; Krul, JM; Thijssen, JH; van Praag, HM; van Ree, JM; Verhoeven, WM; Westenberg, HG | 1 |
Bartfai, A; Edman, G; Levander, SE; Schalling, D; Sedvall, G | 1 |
Davis, KL; Losonczy, MF; Mohs, RC | 1 |
Iselius, L; Nybäck, H; Oreland, L; Oxenstierna, G; Ross, SB; Sedvall, G; Wiesel, FA | 1 |
Potter, WZ | 1 |
Anderson, GM; Cohen, DJ; Fairbanks, L; Gerner, RH; Hare, TA; Linnoila, M; Scheinin, M; Shaywitz, BA; Young, JG | 1 |
Charney, DS; Hafstad, KM; Heninger, GR; Landis, DH; Leckman, JF; Sternberg, DE | 1 |
Davis, JM; DeMet, E; Gibbons, RD; Halaris, A; Ostrow, DG | 1 |
Antelman, S; van Kammen, DP | 1 |
Arora, RC; Meltzer, HY; Metz, J | 1 |
Dysken, MW; Javaid, JI; Mueser, KT; Rosen, AJ | 1 |
Berman, KF; Karoum, F; Karson, CN; Kleinman, J | 1 |
Bowers, MB; Goicoechea, N; Jatlow, PI; Swigar, ME | 1 |
Angrist, B; Gershon, S; Heckl, K; Karobath, M; Lautin, A; Stanley, M | 1 |
Hechun, L; Wenhe, Z; Yucun, S | 1 |
Jeste, DV; Kleinman, JE; Luchins, DJ; Potkin, SG; Weinberger, DR; Wyatt, RJ | 1 |
Cole, JO; Kruger, ER; Maruta, T; Orsulak, PJ; Rosenbaum, AH; Schatzberg, AF; Schildkraut, JJ | 1 |
Bunney, WE; Docherty, JP; Ebert, MH; Marder, SR; Rayner, JN; Rosenblatt, JE; van Kammen, DP | 1 |
Bartels, M; Gaertner, HJ; Golfinopoulos, G | 1 |
Hoaki, Y; Ida, Y; Kohno, Y; Nishikawa, T; Tanaka, M | 1 |
Anderson, PJ; Barchas, JD; Berger, PA; Davis, KL; Faull, KF; Kilkowski, J; Kraemer, H | 2 |
Beckmann, H; Goodwin, FK | 1 |
Hattox, S; Heninger, GR; Leckman, JF; Maas, JW; Sweeney, DR | 1 |
Cole, JO; Kruger, ER; Orsulak, PJ; Rosenbaum, AH; Schatzberg, AF; Schildkraut, JJ | 1 |
Agren, H; Gurklis, J; O'Connor, DT; Peters, JL; van Kammen, DP; Yao, JK | 1 |
Apter, S; Davidson, M; Davis, KL; Harvey, PD; Kahn, RS; Keefe, RS; Mohs, RC; Neale, JM | 1 |
Inanaga, K; Kuniyoshi, M; Miura, C; Nakamura, J | 1 |
Bissette, G; Breslin, NA; Lowrimore, P; Nemeroff, CB; Suddath, RL; Weinberger, DR | 1 |
Csernansky, JG; Faull, KF; Faustman, WO; Jackson, K; Lombrozo, L; Newcomer, JW; Pfefferbaum, A; Zipursky, R | 1 |
Gilbertson, MW; Gurklis, JA; Kelley, ME; Peters, JL; van Kammen, DP; Yao, JK | 1 |
Casanova, MF; Karoum, F; Wyatt, RJ | 1 |
Bartko, JJ; Colison, J; Doran, AR; Hsiao, JK; Konicki, PE; Pickar, D; Potter, WZ | 1 |
Manji, HK; Potter, WZ | 1 |
Amin, F; Apter, S; Davidson, M; Kahn, RS; Knott, PJ; Schmeidler, J; Stern, R | 1 |
Fleischhaker, C; Remschmidt, H; Schulz, E | 1 |
Eggers, C; Oades, RD; Röpcke, B | 1 |
Davis, JM; Faull, K; Janicak, PG; Javaid, JI; Sharma, RP | 1 |
Adler, LE; Baker, N; Cawthra, E; Dubester, S; Madison, A; Nagamoto, H; Scherzinger, A; Simon, J; Staunton, M; Waldo, MC | 1 |
Bowden, C; Castiglioni, J; Contreras, S; Maas, JW; Miller, AL; Seleshi, E; True, JE | 1 |
Kelsoe, JR; Konicki, PE; Pato, C; Pickar, D; Rapaport, MH; Wolkowitz, O | 1 |
Bowers, MB; Bremner, JD; Charney, DS; Delaney, R; Freeman, GK; Heninger, GR; Karper, LP; Krystal, JH; Seibyl, JP | 1 |
Bowers, MB | 2 |
Alam, MY; Boshes, RA; Fitzgibbon, ME; Green, AI; Pappalardo, KM; Schildkraut, JJ; Tsuang, MT; Waternaux, C | 1 |
Berman, N; Bowden, CL; Contreras, SA; Javors, MA; Maas, JW; Miller, AL; Seleshi, E; Weintraub, SE | 1 |
Berman, N; Bowden, CL; Contreras, SA; Javors, MA; Maas, JW; Miller, AL; Seleshi, E; Weintraub, S | 1 |
Alam, MY; Green, AI; Pappalardo, KM; Salzman, C; Schatzberg, AF; Schildkraut, JJ; Sobieraj, JT; Waternaux, C | 1 |
Elkashef, AM; Green, JP; Jaeger, AC; Kaufmann, CA; Khandelwal, JK; Kirch, DG; Lawson, WB; Linnoila, M; Prell, GD; Wyatt, RJ | 1 |
Fukuda, M; Hata, A; Hiramatsu, K; Honda, H; Iwanami, A; Nakagome, K; Niwa, S | 1 |
Demisch, L; Eckert, J; Gille, B; Northoff, G; Pflug, B; Wenke, J | 1 |
Gilbertson, MW; Gurklis, JA; Inosaka, T; Kelley, ME; Peters, JL; Saito, H; Sato, M; van Kammen, DP; Yao, JK | 1 |
Campion, D; Dollfus, S; Dourmap, N; Laurent, C; Mallet, J; Meloni, R; Ménard, JF; Petit, M; Ribeyre, JM; Thibaut, F | 1 |
Garver, DL; Ottong, SE | 1 |
Fleischhaker, C; Remschmidt, HE; Schulz, E | 1 |
Breier, A; Elman, I; Goldstein, DS | 1 |
Amador, XF; Brébion, G; Brown, AS; Cooper, T; Gewirtz, G; Gorman, JM; Harkavy-Friedman, J; Malaspina, D | 1 |
Dollfus, S; Dourmap, N; Ménard, JF; Petit, M; Ribeyre, JM; Thibaut, F | 1 |
Geijer, T; Gyllander, A; Jönsson, EG; Sedvall, GC; Terenius, L | 1 |
Hatzimanolis, J; Lykouras, L; Markianos, M; Oulis, P | 1 |
Adler, LE; Cawthra, E; Gerhardt, G; Griffith, J; Hea, R; Huettl, P; McRae, KA; Nagamoto, HT | 1 |
Kelley, ME; van Kammen, DP; Yao, JK | 1 |
Nakamura, J; Terao, T; Ueda, N; Yoshimura, R | 1 |
Breese, GR; Lipton, MA; Prange, AJ; Wilson, IC | 1 |
Bjerkenstedt, L; Gullberg, B; Härnryd, C; Sedvall, G | 2 |
Casper, RC; Davis, JM; Dekirmenjian, H; Garver, DL; Pandey, GN | 1 |
Bjerkenstedt, L; Lindström, L; Sedvall, G; Wode-Helgodt, B | 1 |
Ackenheil, M; Eben, E; Rüther, E | 1 |
Mitsunobu, K; Nagao, T; Ohshimo, T; Otsuki, S; Sato, M | 1 |
Baker, HF; Crow, TJ; Johnstone, EC; Joseph, MH | 2 |
Bjerkenstedt, L; Grimm, VE; Härnryd, C; Sedvall, G | 1 |
Baker, HF; Deakin, JF; Frith, CD; Johnstone, EC; Joseph, MH | 1 |
Peters, JG | 1 |
Hyyppä, S; Kampman, R; Myllylä, V; Ranta, P; Rimón, R; Roos, BE | 1 |
Heninger, GR; Kirstein, LS; Maas, JW; Sweeney, DR; Taube, SL | 1 |
Heninger, GR; Maas, JW; Sweeney, DR | 1 |
Cole, JO; Gudeman, JE; LaBrie, RA; Orsulak, PJ; Rohde, WA; Schatzberg, AF; Schildkraut, JJ | 2 |
Goodwin, FK; Post, RM | 1 |
Beckmann, H; Belmaker, R; Buchsbaum, M; Ciaranello, P; Goodwin, F; Lamrecht, F; Murphy, D; Pollin, W; Wyatt, R | 1 |
Subrahmanyam, S | 1 |
Carpenter, WT; Fink, E; Goodwin, FK; Post, RM | 1 |
Goodwin, FK; Gordon, EK; Jimerson, DC; Post, RM | 1 |
Honda, K; Horikoshi, R; Kaneko, M; Kanno, T; Kumashiro, H; Manome, T; Watanabe, A | 1 |
Arvanitis, Y; Botsis, A; Markianos, M | 1 |
Carreira, I; Casique, M; Lima, L; Morales, M; Silva, C | 1 |
Adler, L; Baker, N; Drebing, C; Freedman, R; Gerhardt, G; Waldo, M | 1 |
Bowers, MB; Jatlow, PI; Mazure, CM; Nelson, JC | 3 |
Gurklis, J; Nofzinger, E; O'Connor, D; Peters, JL; van Kammen, DP; Yao, J | 1 |
Linnoila, M; Neylan, T; Peters, J; Shaw, D; van Kammen, DP; van Kammen, WB; Yao, J | 1 |
Ishiguro, T; Nisijima, K | 1 |
Breier, A; Doran, AR; Hsiao, JK; Konicki, PE; Pato, CN; Pickar, D; Potter, WZ; Wolkowitz, OM | 1 |
Imai, T; Kai, S; Kajimura, N; Kaneyuki, H; Mizuki, Y; Suetsugi, M; Yamada, M | 1 |
Csernansky, JG; Faull, KF; Jibson, M | 1 |
Wiesel, FA; Wik, G | 1 |
Beuger, M; Neylan, T; O'Connor, DT; Peters, J; Pontius, E; van Kammen, DP; Yao, J | 1 |
Chang, WH; Chen, TY; Hu, WH; Lin, SK; Lin, WL; Lung, FW; Yeh, EK | 1 |
Adler, LE; Baker, NJ; Drebing, C; Freedman, R; Gerhardt, GA; Nagamoto, H; Staunton, M; Waldo, M | 1 |
Adler, LE; Baker, N; Drebing, C; Franks, R; Freedman, R; Gerhardt, GA; Nagamoto, H | 1 |
Linnoila, M; Mazonson, A; Ninan, P; Paul, SM; Pickar, D; Roy, A; Van Kammen, D | 1 |
Bjerkenstedt, L; Edman, G; Hagenfeldt, L; Sedvall, G; Wiesel, FA | 1 |
Peters, J; van Kammen, DP; van Kammen, WB | 1 |
Brown, GL; Goodwin, FK | 1 |
Agren, H; Breier, A; Colison, J; Doran, A; Pickar, D; Roy, A; Wolkowitz, O | 1 |
Gottfries, CG; Gottfries, J; Karlsson, I; Långström, G; Parnetti, L; Svennerholm, L | 1 |
Sedvall, G; Swahn, CG | 1 |
Cooper, SJ; Green, DF; King, DJ; Leahey, W | 1 |
Csernansky, JG; Faull, KF; Pfefferbaum, A | 1 |
Widerlöv, E | 1 |
Ho, SL; Ko, HC; Lin, WL; Lin, YT; Lu, RB | 1 |
Linnoila, M; McAdam, D; Peters, JL; Rosen, J; van Kammen, DP; van Kammen, WB; Yao, JK | 1 |
Goetz, KL; Linnoila, M; Nugent, A; Peters, J; van Kammen, DP; van Kammen, WB; Yao, J | 1 |
Cooper, T; Johns, C; Kane, J; Lieberman, J; Pollack, S | 1 |
Bjerkenstedt, L | 1 |
Breier, A | 1 |
Bowers, MB; Charney, DS; Glazer, WM; Heninger, GR | 1 |
Brown, RP; Mann, JJ | 1 |
Boronow, J; Hommer, D; Linnoila, M; Ninan, PT; Paul, SM; Pickar, D; Roy, A | 1 |
Shigetomi, S | 1 |
Ackenheil, M; Hippius, H; Müller-Spahn, F | 1 |
Zhang, LD | 1 |
Jaskiw, G; Kirch, DG; Linnoila, M; Weinberger, DR; Wyatt, RJ | 1 |
Pickar, D | 1 |
Davis, JM; Javaid, JI; Mueser, KT; Rosen, AJ | 1 |
Bowden, CL; Contreras, SA; Maas, JW; Seleshi, E | 1 |
Bigelow, LB; Jimerson, DC; Ko, GN; Wyatt, RJ | 1 |
Markianos, M; Tripodianakis, J | 1 |
Breier, A; Doran, AR; Labarca, R; Narang, PK; Pickar, D; Roy, A; Wolkowitz, OM | 1 |
Lo, HC; Shen, YC; Shu, LN; Zhou, DF | 1 |
Charney, DS; Glazer, WM; Heninger, GR | 1 |
Bridge, TP; Karoum, F; Kleinman, JE; Soldo, BJ | 1 |
Bridge, TP; Karoum, F; Kleinman, JE; Wyatt, RJ | 1 |
Ackenheil, M; Beckmann, H; Hoffmann, G; Markianos, E; Nyström, I; Raese, J | 1 |
Angrist, B; Gershon, S; Sathananthan, G; Wilk, S | 1 |
Stancer, HC | 1 |
Chanley, JD; Leighton, WP; Rosenblatt, S | 1 |
Ackenheil, M; Beckmann, H; Greil, W; Hoffmann, G; Markianos, E; Raese, J | 1 |
16 review(s) available for methoxyhydroxyphenylglycol and Schizophrenia
Article | Year |
---|---|
[3-methoxy-4-hydroxyphenylglycol (MHPG)].
Topics: Alzheimer Disease; Anorexia Nervosa; Biomarkers; Bipolar Disorder; Chromatography, High Pressure Liquid; Depression; Fatigue Syndrome, Chronic; Gas Chromatography-Mass Spectrometry; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Reference Values; Schizophrenia; Specimen Handling | 2005 |
The year ... psychiatry.
Topics: Affective Symptoms; Behavior Therapy; Brain; Electroconvulsive Therapy; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Psychiatry; Psychophysiologic Disorders; Psychotherapy; Psychotropic Drugs; Schizophrenia | 1980 |
Psychopathology: biological approaches.
Topics: Adoption; Adrenocorticotropic Hormone; Antipsychotic Agents; Brain; Dexamethasone; Diseases in Twins; Evoked Potentials; Genetic Linkage; Genetic Markers; HLA Antigens; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Models, Genetic; Monoamine Oxidase; Radionuclide Imaging; Schizophrenia; Schizophrenia, Paranoid | 1983 |
Genetic studies of CSF monoamine metabolites.
Topics: Biogenic Amines; Blood Platelets; Dopamine beta-Hydroxylase; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Pregnancy; Schizophrenia; Twins, Dizygotic; Twins, Monozygotic | 1984 |
Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications.
Topics: Antidepressive Agents; Biogenic Amines; Dopamine; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Mood Disorders; Neurotransmitter Agents; Norepinephrine; Normetanephrine; Psychotropic Drugs; Schizophrenia; Serotonin | 1984 |
Impaired noradrenergic transmission in schizophrenia?
Topics: Alprostadil; Blood Platelets; Brain; Cyclic AMP; Dopamine; Dopamine beta-Hydroxylase; Female; Forecasting; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Prostaglandins E; Receptors, Adrenergic; Schizophrenia; Sex Factors; Synaptic Transmission | 1984 |
The schizophrenia syndrome. Examples of biological tools for subclassification.
Topics: Amphetamine; Blood Platelets; Dominance, Cerebral; Dyskinesia, Drug-Induced; Functional Laterality; Humans; Hypothalamus; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Norepinephrine; Nucleus Accumbens; Phenethylamines; Schizophrenia; Schizophrenia, Paranoid; Tomography, X-Ray Computed | 1981 |
Clozapine response and plasma catecholamines and their metabolites.
Topics: Adult; Brain; Catecholamines; Clozapine; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia | 1993 |
Behavioral effects of hypothalamic releasing hormones in animals and men.
Topics: Animals; Behavior; Brain; Child; Depression; Female; Gonadotropin-Releasing Hormone; Humans; Hyperkinesis; Methoxyhydroxyphenylglycol; Mice; Motor Activity; MSH Release-Inhibiting Hormone; Norepinephrine; Pentobarbital; Rats; Schizophrenia; Somatostatin; Temperature; Thyrotropin-Releasing Hormone; Tyrosine | 1975 |
Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antidepressive Agents, Tricyclic; Bipolar Disorder; Brain; Depression; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mandelic Acids; Methoxyhydroxyphenylglycol; Norepinephrine; Probenecid; Remission, Spontaneous; Schizophrenia; Serotonin; Tranquilizing Agents | 1975 |
Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antipsychotic Agents; Catecholamines; Cyclic AMP; Dopamine; Dopamine beta-Hydroxylase; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Norepinephrine; Schizophrenia; Serotonin; Tyrosine 3-Monooxygenase; Vanilmandelic Acid | 1986 |
A critical appraisal of CSF monoamine metabolite studies in schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biogenic Monoamines; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Schizophrenia | 1988 |
A clinical perspective on the role of neurotransmitters in mental disorders.
Topics: Antidepressive Agents; Brain Chemistry; Cyclic AMP; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Receptors, Neurotransmitter; Schizophrenia; Serotonin; Suicide | 1985 |
Neuroendocrinological and biochemical effects of chronic neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Apomorphine; beta-Endorphin; Drug Tolerance; Endocrine System Diseases; Endorphins; Female; Genetic Variation; Homovanillic Acid; Humans; Hydrocortisone; Hypothalamus; Luteinizing Hormone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nervous System Diseases; Norepinephrine; Prolactin; Receptors, Adrenergic, alpha; Receptors, Dopamine; Schizophrenia; Thyrotropin | 1985 |
Perspectives on a time-dependent model of neuroleptic action.
Topics: Antipsychotic Agents; Brain; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 1988 |
Psychopharmacology. Yesterday, today and tomorrow: a point of view.
Topics: Affective Symptoms; Amitriptyline; Antidepressive Agents; Canada; Carbonates; Depression; Dihydroxyphenylalanine; Drug Industry; Electroconvulsive Therapy; Humans; Imipramine; Lithium; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Nicotinic Acids; Psychopharmacology; Research Support as Topic; Schizophrenia; Tranquilizing Agents; Tryptophan; Vitamins | 1973 |
33 trial(s) available for methoxyhydroxyphenylglycol and Schizophrenia
Article | Year |
---|---|
Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Piperazines; Piperidines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Time Factors; Treatment Outcome | 2014 |
Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Benzamides; Biogenic Monoamines; Brain Mapping; Dibenzothiazepines; Fluorine Radioisotopes; Homovanillic Acid; Humans; Magnetic Resonance Imaging; Male; Methoxyhydroxyphenylglycol; Middle Aged; Pilot Projects; Positron-Emission Tomography; Protein Binding; Pyrrolidines; Quetiapine Fumarate; Receptors, Dopamine D2; Schizophrenia; Tritium; Young Adult | 2010 |
Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
Topics: Acute Disease; Adult; Alleles; Antipsychotic Agents; Aripiprazole; Female; Genetic Carrier Screening; Genotype; Homovanillic Acid; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Piperazines; Polymorphism, Genetic; Psychiatric Status Rating Scales; Quinolones; Receptors, Dopamine D2; Schizophrenia; Taq Polymerase; Treatment Outcome; Young Adult | 2012 |
Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain-Derived Neurotrophic Factor; Case-Control Studies; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Homovanillic Acid; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Piperazines; Polymorphism, Genetic; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Time Factors; Young Adult | 2012 |
Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2012 |
Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Risperidone; Schizophrenia; Treatment Outcome | 2003 |
Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Catecholamines; Cytokines; Female; Homovanillic Acid; Humans; Interleukin-2; Interleukin-6; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
The effect of propranolol on CSF amine metabolites in psychiatric patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenylacetates; Propranolol; Schizophrenia | 1983 |
Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Patient Compliance; Prolactin; Schizophrenia; Sulpiride | 1984 |
Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Endorphins; Female; Growth Hormone; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Peptide Fragments; Prolactin; Schizophrenia; Schizophrenia, Disorganized; Schizophrenia, Paranoid | 1984 |
Sodium valproate in schizophrenia: some biochemical correlates.
Topics: Adult; Clinical Trials as Topic; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Valproic Acid | 1980 |
Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics.
Topics: Adult; Dopamine Antagonists; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Raclopride; Salicylamides; Schizophrenia; Schizophrenic Psychology | 1994 |
Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
Topics: Adult; Antipsychotic Agents; Brain; Debrisoquin; Dopamine; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Placebos; Plasma; Schizophrenia | 1993 |
Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Naltrexone; Narcotic Antagonists; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1993 |
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Topics: Adult; Blood Pressure; Cognition; Dissociative Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Frontal Lobe; Homovanillic Acid; Humans; Hydrocortisone; Ketamine; Male; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Perception; Prolactin; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Pulse; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology | 1994 |
Studies of catecholamine metabolism in schizophrenia/psychosis--II.
Topics: Adult; Aged; Analysis of Variance; Catecholamines; Circadian Rhythm; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 1993 |
Studies of catecholamine metabolism in schizophrenia/psychosis--I.
Topics: Adult; Aged; Analysis of Variance; Blood Platelets; Catecholamines; Debrisoquin; Double-Blind Method; Homovanillic Acid; Humans; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Psychometrics; Schizophrenia; Schizophrenic Psychology | 1993 |
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Lorazepam; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia | 1995 |
Predicting haloperidol treatment response in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1996 |
Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Clozapine; Female; Humans; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Prolactin; Schizophrenia; Serotonin | 1996 |
Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
Topics: Aged; Analysis of Variance; Antipsychotic Agents; Clozapine; Haloperidol; Homovanillic Acid; Humans; Hydrocortisone; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Prolactin; Psychotic Disorders; Schizophrenia | 1997 |
Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia.
Topics: Aged; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1998 |
Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol.
Topics: Adult; Antipsychotic Agents; Clozapine; Electroencephalography; Evoked Potentials, Auditory; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1999 |
Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement.
Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Serotonin Antagonists; Treatment Outcome | 2000 |
Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.
Topics: Antipsychotic Agents; Butyrophenones; Clinical Trials as Topic; Double-Blind Method; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Phenylacetates; Piperidines; Schizophrenia; Thiothixene | 1977 |
3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol.
Topics: Adult; Clinical Trials as Topic; Female; Flupenthixol; Glycols; Humans; Isomerism; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Thioxanthenes | 1979 |
Clonidine treatment of schizophrenia: can we predict treatment response?
Topics: Adult; Clinical Trials as Topic; Clonidine; Growth Hormone; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |
Melperone in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Butyrophenones; Diazepam; Double-Blind Method; Drug Therapy, Combination; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiothixene | 1989 |
A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients.
Topics: Adrenocorticotropic Hormone; Adult; Arousal; beta-Endorphin; Blood Glucose; Clinical Trials as Topic; Deoxyglucose; Depressive Disorder; Double-Blind Method; Epinephrine; Female; Fluphenazine; Grief; Homovanillic Acid; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Mood Disorders; Norepinephrine; Pituitary-Adrenal System; Schizophrenia; Stress, Psychological | 1989 |
Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain; Catecholamines; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1988 |
Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH.
Topics: Adult; Clinical Trials as Topic; Clonidine; Dopamine beta-Hydroxylase; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 1986 |
Clinical and biochemical effects of verapamil administration to schizophrenic patients.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Emotions; Female; Homovanillic Acid; Hostility; Humans; Male; Methoxyhydroxyphenylglycol; Placebos; Prolactin; Schizophrenia; Schizophrenic Psychology; Verapamil | 1987 |
Noradrenergic function in schizophrenia.
Topics: Adult; Arousal; Blood Pressure; Dopamine; Dyskinesia, Drug-Induced; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Pulse; Schizophrenia; Schizophrenic Psychology; Yohimbine | 1987 |
137 other study(ies) available for methoxyhydroxyphenylglycol and Schizophrenia
Article | Year |
---|---|
Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute schizophrenia.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cognition; Female; Homovanillic Acid; Hospitalization; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Predictive Value of Tests; Schizophrenia; Schizophrenic Psychology; Young Adult | 2020 |
Plasma monoamines change under dopamine supersensitivity psychosis in patients with schizophrenia: A comparison with first-episode psychosis.
Topics: Adult; Aged; Antipsychotic Agents; Dopamine; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychotic Disorders; Receptors, Dopamine D2; Recurrence; Schizophrenia; Young Adult | 2020 |
No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Topics: Adolescent; Adult; Biogenic Monoamines; Biomarkers; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Psychotic Disorders; Schizophrenia; Tobacco Smoking; Young Adult | 2018 |
Influence of -141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Homovanillic Acid; Humans; INDEL Mutation; Male; Methoxyhydroxyphenylglycol; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology | 2015 |
Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Schizophrenic Psychology; Symptom Assessment | 2015 |
Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Topics: Adult; Antipsychotic Agents; Biomarkers; Brain-Derived Neurotrophic Factor; Case-Control Studies; Chronic Disease; Cognition; Cytokines; Female; Homovanillic Acid; Humans; Intelligence Tests; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Young Adult | 2017 |
Genetic and Functional Study of L-Type Amino Acid Transporter 1 in Schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cells, Cultured; Female; Fibroblasts; Genetic Predisposition to Disease; Homovanillic Acid; Humans; Large Neutral Amino Acid-Transporter 1; Male; Methoxyhydroxyphenylglycol; Middle Aged; Polymorphism, Single Nucleotide; Protein Isoforms; Schizophrenia; Tyrosine; Young Adult | 2016 |
Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain-Derived Neurotrophic Factor; Cognition; Executive Function; Female; Homovanillic Acid; Humans; Male; Memory, Short-Term; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 2017 |
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cognition Disorders; Female; Frontal Lobe; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurons; Neuropsychological Tests; Norepinephrine; Schizophrenia; Young Adult | 2009 |
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Female; Homovanillic Acid; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Young Adult | 2010 |
Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls.
Topics: Adolescent; Adult; Aspartic Acid; Basal Ganglia; Brain Chemistry; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Homovanillic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Methoxyhydroxyphenylglycol; Middle Aged; Occipital Lobe; Parietal Lobe; Schizophrenia; Young Adult | 2011 |
Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
Topics: Adolescent; Adult; Biomarkers; Dibenzothiazepines; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Quetiapine Fumarate; Schizophrenia; Treatment Outcome; Young Adult | 2010 |
[3-Methoxy-4 -hydroxyphenylglycol (MHPG)].
Topics: Gas Chromatography-Mass Spectrometry; Humans; Methoxyhydroxyphenylglycol; Schizophrenia | 2010 |
Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanilli
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Female; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Risperidone; Schizophrenia; Serotonin; Tryptophan | 2002 |
Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
Topics: Adult; Antipsychotic Agents; Biogenic Monoamines; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Serotonin | 2002 |
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catecholamines; Central Nervous System Stimulants; Cotinine; Cues; Cytochrome P-450 CYP2D6; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking | 2005 |
Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Drug Interactions; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychomotor Agitation; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 2007 |
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Catecholamines; Chromatography, High Pressure Liquid; Female; Genotype; Humans; Immunoenzyme Techniques; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone; Schizophrenia | 2007 |
[The probenecid test and its application to research in schizophrenia].
Topics: Biogenic Amines; Brain; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Probenecid; Schizophrenia | 1984 |
[Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
Topics: Adult; Antipsychotic Agents; Biogenic Amines; Chronic Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Probenecid; Schizophrenia | 1984 |
The Genain Quadruplets 25 years later: a diagnostic and biochemical followup.
Topics: 3,4-Dihydroxyphenylacetic Acid; Cyclic AMP; Dopamine beta-Hydroxylase; Environment; Female; Follow-Up Studies; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Phenethylamines; Pregnancy; Quadruplets; Receptors, Adrenergic, alpha; Schizophrenia | 1984 |
Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
Topics: Antipsychotic Agents; Dopamine beta-Hydroxylase; Dyskinesia, Drug-Induced; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 1983 |
Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
Topics: Adolescent; Adult; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenylacetates; Schizophrenia; Spinal Puncture | 1980 |
Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Phenylacetates; Psychotic Disorders; Schizophrenia | 1980 |
Biological quantitative methods in the evaluation of psychiatric treatment: some biochemical criteria.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Catechol O-Methyltransferase; Electroconvulsive Therapy; Humans; Hydroxyindoleacetic Acid; Lithium; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Mood Disorders; Neurotransmitter Agents; Prognosis; Schizophrenia | 1982 |
Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
Topics: Aged; Alcohol Amnestic Disorder; Alzheimer Disease; Dementia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Somatostatin | 1982 |
Gamma-hydroxybutyrate in the treatment of schizophrenia.
Topics: Adult; Double-Blind Method; Homovanillic Acid; Humans; Hydroxybutyrates; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sodium Oxybate | 1983 |
Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Eye Movements; Female; Galvanic Skin Response; Habituation, Psychophysiologic; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Schizophrenia | 1983 |
Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers.
Topics: Adult; Age Factors; Cerebral Ventriculography; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Psychotic Disorders; Schizophrenia; Tomography, X-Ray Computed | 1983 |
Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
Topics: Adult; Chronic Disease; Female; Glycols; Homovanillic Acid; Hospitalization; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Phenylacetates; Schizophrenia; Schizophrenic Psychology; Spinal Puncture; Time Factors | 1983 |
Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients.
Topics: Adolescent; Adult; Cerebrospinal Fluid Proteins; Chlorpromazine; Dopamine Antagonists; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Prolactin; Receptors, Dopamine D2; Schizophrenia; Sulpiride; Time Factors | 1984 |
Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Norepinephrine; Schizophrenia | 1984 |
Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia.
Topics: Adult; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Evaluation; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Propranolol; Regression Analysis; Schizophrenia | 1984 |
Bilateral skin conductance activity, clinical symptoms and CSF monoamine metabolite levels in unmedicated schizophrenics, differing in rate of habituation.
Topics: Adult; Biogenic Amines; Female; Galvanic Skin Response; Habituation, Psychophysiologic; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Paranoid Disorders; Schizophrenia | 1984 |
Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
Topics: Adult; Alzheimer Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Schizophrenia; Seasons | 1984 |
CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
Topics: Adolescent; Adult; Age Factors; Aged; Bipolar Disorder; Calcium; Choline; Depressive Disorder; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Research Design; Schizophrenia; Tryptophan; Tyrosine | 1984 |
Impaired presynaptic regulation of norepinephrine in schizophrenia. Effects of clonidine in schizophrenic patients and normal controls.
Topics: Adult; Blood Pressure; Brain; Clonidine; Dose-Response Relationship, Drug; Female; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Receptors, Adrenergic; Schizophrenia; Synapses | 1982 |
Ion transport and adrenergic function in major affective disorder.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Depressive Disorder; Erythrocyte Membrane; Erythrocytes; Humans; Ion Channels; Lithium; Methoxyhydroxyphenylglycol; Norepinephrine; Psychotic Disorders; Schizophrenia; Sodium | 1982 |
Biological studies of schizoaffective disorders.
Topics: Blood Platelets; Catechol O-Methyltransferase; Dexamethasone; Dopamine; Dopamine beta-Hydroxylase; gamma-Aminobutyric Acid; Humans; Hydrocortisone; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Norepinephrine; Psychotic Disorders; Schizophrenia; Serotonin; Sleep, REM; Thyrotropin; Thyrotropin-Releasing Hormone | 1984 |
Urinary MHPG and ward behavior in unmedicated psychiatric patients.
Topics: Adult; Bipolar Disorder; Creatinine; Depressive Disorder; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Social Adjustment; Social Behavior; Social Environment | 1983 |
Seasonal variation in human central dopamine activity.
Topics: Adult; Blinking; Brain Chemistry; Dopamine; Female; Homovanillic Acid; Humans; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Nucleus Accumbens; Schizophrenia; Seasons | 1984 |
Plasma catecholamine metabolites and early response to haloperidol.
Topics: Acute Disease; Adolescent; Adult; Female; Glycols; Haloperidol; Homovanillic Acid; Hospitalization; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Outcome and Process Assessment, Health Care; Phenylacetates; Prolactin; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Sex Factors | 1984 |
The effect of electric acupuncture treatment on urinary MHPG-sulphate excretion in unmedicated schizophrenics.
Topics: Acupuncture Therapy; Adult; Electric Stimulation Therapy; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 1981 |
Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Glycols; Humans; Methoxyhydroxyphenylglycol; Psychotic Disorders; Schizophrenia; Vanilmandelic Acid | 1982 |
d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia.
Topics: Adolescent; Adult; Dextroamphetamine; Double-Blind Method; Female; Humans; Infusions, Parenteral; Male; Methoxyhydroxyphenylglycol; Middle Aged; Placebos; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1982 |
Acathisia-syndrome: involvement of noradrenergic mechanisms.
Topics: Adult; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychomotor Agitation; Reference Values; Schizophrenia; Syndrome | 1981 |
Effect of haloperidol administration on serum MHPG-SO4 levels in chronic schizophrenics.
Topics: Adult; Biotransformation; Brain; Chronic Disease; Glycols; Haloperidol; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Schizophrenia | 1981 |
CSF monoamine metabolites in depression and schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Probenecid; Schizophrenia | 1980 |
Urinary MHPG in subgroups of depressed patients and normal controls.
Topics: Adult; Age Factors; Aged; Anxiety; Bipolar Disorder; Blood Pressure; Depression; Diastole; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Sex Factors; Systole | 1980 |
Plasma free and conjugated MHPG in psychiatric patients. A pilot study.
Topics: Adult; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Mood Disorders; Norepinephrine; Pilot Projects; Schizophrenia | 1980 |
Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Catecholamines; Depressive Disorder; Epinephrine; Humans; Metanephrine; Methoxyhydroxyphenylglycol; Norepinephrine; Normetanephrine; Schizophrenia; Vanilmandelic Acid | 1980 |
Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia.
Topics: Adult; Chromogranin A; Chromogranins; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Logistic Models; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Placebos; Probability; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1994 |
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
Topics: Adult; Cerebral Cortex; Cognition Disorders; Discrimination Learning; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Recall; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Serotonin; Wechsler Scales | 1994 |
Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia.
Topics: Adult; Biogenic Monoamines; Chronic Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Mianserin; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists | 1994 |
CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates.
Topics: Adult; Female; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurotensin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia.
Topics: Adult; Age of Onset; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Logistic Models; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Placebos; Probability; Psychiatric Status Rating Scales; Recurrence; Regression Analysis; ROC Curve; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1995 |
Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Age Factors; Aged; Antipsychotic Agents; Autopsy; Female; Gas Chromatography-Mass Spectrometry; Gyrus Cinguli; Homovanillic Acid; Humans; Male; Medical Records; Methoxyhydroxyphenylglycol; Middle Aged; Normetanephrine; Psychiatric Status Rating Scales; Schizophrenia | 1995 |
Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Topics: Adult; Antipsychotic Agents; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Stimulation, Chemical | 1993 |
Are monoamine metabolites in cerebrospinal fluid worth measuring?
Topics: Animals; Brain; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Rats; Research Design; Schizophrenia; Serotonin | 1993 |
Assessment of the central dopaminergic index of plasma HVA in schizophrenia.
Topics: Brain; Debrisoquin; Dopamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Neurons; Norepinephrine; Predictive Value of Tests; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1995 |
[Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Clozapine; Depressive Disorder; Dopamine; Epinephrine; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Serotonin; Treatment Outcome | 1994 |
Monoamine activity reflected in urine of young patients with obsessive compulsive disorder, psychosis with and without reality distortion and healthy subjects: an explorative analysis.
Topics: Adolescent; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Creatinine; Dopamine; Epinephrine; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Obsessive-Compulsive Disorder; Psychotic Disorders; Schizophrenia; Serotonin | 1994 |
CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Blood-Brain Barrier; Brain; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Psychotic Disorders; Schizophrenia | 1994 |
Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings.
Topics: Acoustic Stimulation; Adult; Amygdala; Arousal; Attention; Catecholamines; Chronic Disease; Dopamine; Evoked Potentials, Auditory; Female; Habituation, Psychophysiologic; Hippocampus; Homovanillic Acid; Humans; Magnetic Resonance Imaging; Male; Methoxyhydroxyphenylglycol; Neural Inhibition; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Vanilmandelic Acid | 1994 |
Psychotic patients with increased plasma HVA and MHPG or increased HVA alone.
Topics: Adult; Arousal; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1993 |
Haloperidol response and plasma catecholamines and their metabolites.
Topics: Adult; Catecholamines; Dopamine; Female; Haloperidol; Homovanillic Acid; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1993 |
The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Biogenic Amines; Chronic Disease; Drinking; Female; Histamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Methylhistamines; Middle Aged; Norepinephrine; Polyuria; Reference Values; Schizophrenia; Water-Electrolyte Balance | 1996 |
Exaggerated responsivity of brain dopaminergic system activity in schizophrenia: a preliminary finding of increased variance of plasma homovanillic acid level in a chronic patient.
Topics: Adult; Brain; Chronic Disease; Dopamine; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Vanilmandelic Acid | 1996 |
Association of DNA polymorphism in the first intron of the tyrosine hydroxylase gene with disturbances of the catecholaminergic system in schizophrenia.
Topics: Adult; Analysis of Variance; Case-Control Studies; Catecholamines; Chi-Square Distribution; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Polymorphism, Genetic; Schizophrenia; Tyrosine 3-Monooxygenase | 1997 |
A biomodal distribution of plasma HVA/MHPG in the psychoses.
Topics: Adult; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Psychotic Disorders; Schizophrenia | 1997 |
Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action.
Topics: Antipsychotic Agents; Clozapine; Fluphenazine; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Regression Analysis; Schizophrenia; Time Factors | 1998 |
Failure to replicate an association between a rare allele of a tyrosine hydroxylase gene microsatellite and schizophrenia.
Topics: Alleles; Gene Expression Regulation, Enzymologic; Gene Frequency; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Microsatellite Repeats; Polymorphism, Genetic; Reference Values; Reproducibility of Results; Schizophrenia; Tyrosine 3-Monooxygenase | 1998 |
Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Clozapine; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Regression Analysis; Schizophrenia | 1998 |
Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia.
Topics: Adult; Antipsychotic Agents; Biomarkers; Bipolar Disorder; Catecholamines; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Outcome Assessment, Health Care; Schizophrenia | 1999 |
Neuroendocrine and amine studies in affective illness.
Topics: Affective Symptoms; Anti-Anxiety Agents; Apomorphine; Biogenic Amines; Blood Glucose; Female; Growth Hormone; Humans; Insulin; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Schizophrenia | 1977 |
Clinical assessment of dopamine receptor blockade.
Topics: Antipsychotic Agents; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Prolactin; Receptors, Dopamine; Schizophrenia | 1978 |
[Norepinephrine turnover under neuroleptic treatment of schizophrenic syndromes (author's transl)].
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Haloperidol; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Schizophrenia | 1978 |
Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
Topics: Adult; Chronic Disease; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Schizophrenia; Tremor; Valproic Acid | 1979 |
Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.
Topics: Butyrophenones; Diazepam; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Paranoid Disorders; Piperidines; Prolactin; Schizophrenia; Therapeutic Equivalency; Thiothixene | 1979 |
Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment.
Topics: Biogenic Amines; Electroconvulsive Therapy; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia | 1979 |
Arousal related to excretion of noradrenaline metabolites and clinical aspects of unmedicated chronic schizophrenic patients.
Topics: Aged; Arousal; Chronic Disease; Galvanic Skin Response; Habituation, Psychophysiologic; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Schizophrenia; Schizophrenic Psychology; Vanilmandelic Acid | 1979 |
Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
Topics: Adolescent; Adult; Child; Dopamine; Epilepsy, Temporal Lobe; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Norepinephrine; Phenobarbital; Schizophrenia; Serotonin | 1979 |
Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
Topics: Atrophy; Brain Diseases; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenylacetates; Psychosurgery; Radiography; Schizophrenia | 1979 |
Urinary 3-methoxy-4-hydroxyphenylglycol and psychiatric diagnosis.
Topics: Adult; Depression; Diagnosis, Differential; Female; Glycols; Humans; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1978 |
State anxiety, physical activity, and urinary 3-methoxy-4-hydroxyphenethylene glycol excretion.
Topics: Adult; Anxiety; Bipolar Disorder; Depression; Female; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Physical Exertion; Schizophrenia | 1978 |
Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
Topics: Adult; Bipolar Disorder; Depression; Epinephrine; Female; Glycols; Humans; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Schizophrenia; Vanilmandelic Acid | 1978 |
Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.
Topics: Adult; Bipolar Disorder; Depression; Epinephrine; Factor Analysis, Statistical; Female; Glycols; Humans; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Schizophrenia; Vanilmandelic Acid | 1978 |
Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients.
Topics: Brain; Glucuronates; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Schizophrenia; Sulfates; Vanilmandelic Acid | 1976 |
Relationships between platelet and plasma monoamine oxidase, plasma dopamine-beta-hydroxylase, and urinary 3-methoxy-4-hydroxy phenylglycol.
Topics: Adolescent; Adult; Blood Platelets; Creatinine; Diseases in Twins; Dopamine beta-Hydroxylase; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Plasma; Schizophrenia | 1975 |
Role of biogenic amines in certain pathological conditions.
Topics: Acute Disease; Adult; Aggression; Biogenic Amines; Bipolar Disorder; Chlorpromazine; Chronic Disease; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Imipramine; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Nialamide; Schizophrenia | 1975 |
Cerebrospinal fluid amine metabolites in acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Amines; Bipolar Disorder; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Probenecid; Schizophrenia; Serotonin; Spinal Puncture | 1975 |
Central noradrenergic function in man: vanillylmandelic acid in CSF.
Topics: Acute Disease; Affective Symptoms; Bipolar Disorder; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Schizophrenia; Vanilmandelic Acid | 1975 |
Plasma free 3-methoxy-4-hydroxyphenylglycol in acute schizophrenics before and after treatment.
Topics: Adult; Antipsychotic Agents; Female; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1992 |
Biogenic amine metabolites in plasma of drug-naive schizophrenic patients: associations with symptomatology.
Topics: Adult; Arousal; Chromatography, High Pressure Liquid; Homovanillic Acid; Hospitalization; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Military Personnel; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1992 |
[Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam].
Topics: Adult; Anxiety Disorders; Clonazepam; Depression; Female; Humans; Imipramine; Lactates; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Paranoid Disorders; Prevalence; Psychological Tests; Schizophrenia | 1992 |
Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects.
Topics: Acoustic Stimulation; Adult; Arousal; Attention; Auditory Pathways; Cerebral Cortex; Electroencephalography; Evoked Potentials, Auditory; Female; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Neural Inhibition; Reference Values; Schizophrenia; Schizophrenic Psychology; Signal Processing, Computer-Assisted; Vanilmandelic Acid | 1992 |
Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
Topics: Adult; Aged; Bipolar Disorder; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Lithium; Male; Methoxyhydroxyphenylglycol; Middle Aged; Perphenazine; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1992 |
CSF noradrenergic activity and sleep EEG in clinically stable schizophrenic patients after haloperidol withdrawal.
Topics: Adult; Dopamine beta-Hydroxylase; Electroencephalography; Haloperidol; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Schizophrenia; Sleep; Sleep, REM; Substance Withdrawal Syndrome | 1992 |
Characteristics of psychotic inpatients with high or low HVA levels at admission.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Female; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Hospitalization; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Sex Factors | 1991 |
Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.
Topics: Acute Disease; Adult; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1990 |
Neuroleptic malignant syndrome: a study of CSF monoamine metabolism.
Topics: Adult; Biogenic Monoamines; Bipolar Disorder; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Intellectual Disability; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuroleptic Malignant Syndrome; Norepinephrine; Schizophrenia | 1990 |
Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
Topics: Adult; Brain; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1990 |
Effects of mianserin on negative symptoms in schizophrenia.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chronic Disease; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Mianserin; Middle Aged; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 1990 |
Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
Topics: Acid-Base Equilibrium; Administration, Oral; Blood-Brain Barrier; Depressive Disorder; Dose-Response Relationship, Drug; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Probenecid; Psychotic Disorders; Schizophrenia | 1990 |
Regional brain glucose metabolism: correlations to biochemical measures and anxiety in patients with schizophrenia.
Topics: Adult; Anxiety; Arousal; Blood Glucose; Brain; Brain Mapping; Dominance, Cerebral; Energy Metabolism; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Prolactin; Reference Values; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed | 1991 |
CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.
Topics: Adult; Arousal; Atrophy; Brain; Chromogranin A; Chromogranins; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Radioimmunoassay; Schizophrenia; Schizophrenic Psychology | 1991 |
Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
Topics: Acute Disease; Adolescent; Adult; Bipolar Disorder; Chromatography, High Pressure Liquid; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Perphenazine; Prognosis; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1991 |
Psychotogenic drug use and neuroleptic response.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Perphenazine; Psychiatric Status Rating Scales; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1990 |
Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.
Topics: Adult; Female; Glycols; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1990 |
Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups.
Topics: Adult; Arousal; Attention; Bipolar Disorder; Brain; Catecholamines; Depressive Disorder; Evoked Potentials, Auditory; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Reaction Time; Schizophrenia; Schizophrenic Psychology; Vanilmandelic Acid | 1990 |
Sensory physiology and catecholamines in schizophrenia and mania.
Topics: Adult; Arousal; Bipolar Disorder; Dopamine; Electroencephalography; Evoked Potentials, Auditory; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Schizophrenia; Schizophrenic Psychology; Sensation; Signal Processing, Computer-Assisted; Vanilmandelic Acid | 1990 |
CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
Topics: Adult; Chronic Disease; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Phenylacetates; Risk; Schizophrenia; Schizophrenic Psychology; Suicide, Attempted | 1985 |
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls.
Topics: Adult; Amino Acids; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Schizophrenia | 1985 |
Cerebrospinal fluid correlates of suicide attempts and aggression.
Topics: Aggression; Animals; Bipolar Disorder; Depressive Disorder; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Schizophrenia; Self Mutilation; Serotonin; Suicide, Attempted | 1986 |
Suicide and aggression in schizophrenia. Neurobiologic correlates.
Topics: Aggression; Brain; Cerebral Ventricles; Dexamethasone; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Schizophrenia; Suicide; Suicide, Attempted; Tomography, X-Ray Computed | 1986 |
Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biogenic Amines; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 1987 |
CSF creatinine in schizophrenia.
Topics: Adult; Blood-Brain Barrier; Creatinine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 1988 |
The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.
Topics: Adult; Aged; Electroconvulsive Therapy; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia | 1988 |
Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?
Topics: Bipolar Disorder; Depressive Disorder; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Psychotic Disorders; Retrospective Studies; Schizophrenia; Seasons | 1988 |
Corrections to a 1980 article on CSF monoamine metabolites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Depressive Disorder; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Schizophrenia | 1989 |
CSF neurochemical study of tardive dyskinesia.
Topics: Acetylcholinesterase; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Schizophrenia | 1989 |
CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
Topics: Adult; Chromatography, High Pressure Liquid; Chronic Disease; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Psychiatric Status Rating Scales; Recurrence; Risk Factors; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1989 |
Clozapine pharmacology and tardive dyskinesia.
Topics: Adolescent; Adult; Clozapine; Dibenzazepines; Dyskinesia, Drug-Induced; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Phenethylamines; Prolactin; Schizophrenia | 1989 |
The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
Topics: Antipsychotic Agents; Brain; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1989 |
Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series.
Topics: Adult; Atrophy; Brain; Cerebellum; Cerebral Cortex; Cerebral Ventricles; Female; Homovanillic Acid; Humans; Hydrocephalus; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Schizophrenia; Tomography, X-Ray Computed | 1985 |
[Clinical significance of 3-methoxy-4-hydroxyphenylethylene glycol analysis in endocrine tests of the medulla and sympathetic nervous system].
Topics: Adrenal Medulla; Alzheimer Disease; Anorexia Nervosa; Chromatography, Gas; Chromatography, High Pressure Liquid; Depressive Disorder; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Reference Values; Schizophrenia; Sympathetic Nervous System | 1989 |
[Traditional Chinese medicine typing of schizophrenia].
Topics: Adult; Cyclic AMP; Dynorphins; Female; Humans; Male; Medicine, Chinese Traditional; Methoxyhydroxyphenylglycol; Peptide Fragments; Schizophrenia | 1987 |
Urinary 3-methoxy-4-hydroxyphenylglycol in affective and schizophrenic patients. Behavior and symptom correlates.
Topics: Adolescent; Adult; Aged; Behavior; Creatinine; Diagnosis-Related Groups; Eating; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Mood Disorders; Physical Exertion; Schizophrenia; Schizophrenic Psychology | 1986 |
Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Blood Platelets; Brain; Debrisoquin; Dopamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1988 |
Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtype.
Topics: Adult; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Recurrence; Schizophrenia; Schizophrenia, Paranoid | 1988 |
Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Dexamethasone; Female; Glycols; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Schizophrenia | 1987 |
Central catecholamines, cognitive impairment, and affective state in elderly schizophrenics and controls.
Topics: 3,4-Dihydroxyphenylacetic Acid; Affect; Aged; Catecholamines; Cognition; Homovanillic Acid; Humans; Hypothalamus; Methoxyhydroxyphenylglycol; Middle Aged; Nucleus Accumbens; Schizophrenia; Schizophrenic Psychology; Septal Nuclei | 1987 |
Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Brain Chemistry; Catecholamines; Cognition; Dementia; Dopamine; Homovanillic Acid; Humans; Hypothalamus; Methoxyhydroxyphenylglycol; Norepinephrine; Nucleus Accumbens; Schizophrenia | 1985 |
[Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid].
Topics: Azepines; Bipolar Disorder; Dopamine beta-Hydroxylase; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Phenylacetates; Piperazines; Schizophrenia; Tranquilizing Agents | 1974 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depression; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Ethylene Glycols; Hallucinations; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Psychoses, Substance-Induced; Receptors, Drug; Schizophrenia; Schizophrenic Language; Schizophrenic Psychology; Stereoisomerism | 1974 |
Dopamine-beta-hydroxylase: evidence for increased activity in sympathetic neurons during psychotic states.
Topics: Bipolar Disorder; Dopamine; Dopamine beta-Hydroxylase; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Methyl Ethers; Neurons; Norepinephrine; Normetanephrine; Saliva; Salivary Glands; Schizophrenia; Sympathetic Nervous System; Tritium; Tyramine; Vanilmandelic Acid | 1973 |
Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.
Topics: Bipolar Disorder; Carbon Radioisotopes; Catecholamines; Chromatography, Gas; Dibenzazepines; Dopamine beta-Hydroxylase; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Time Factors; Tranquilizing Agents | 1974 |